Approval · Notice of Compliance 37875 · 2026
SCENESSE: Notice of Compliance 37875
Issued July 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37875
- Date
- July 9, 2026
- Company
- Clinuvel, Inc.Burlingame, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SCENESSE | 02569825 | Approved |
Medicinal ingredients
- AFAMELANOTIDE ACETATE 16 MG per IMP